Back To Top


Pharma Icon


Our physiology engine is built on over 132,000 parameters.

We can run multiple simulations concurrently.

We have the ability to characterise a new molecule, and to administer patient dosages “in-silico” in multiple simulations, and to observe and record responses.

We are not a pharma company, but we understand health and data science. We know that pharma R&D is costly, time consuming and risky. The same is true of clinical trials.

We aim to help reduce these costs by the early identification of low-frequency responses to a new drug. In so doing, we also aim to reduce the risks associated with the clinical programme.

Please get in touch if you would like to discuss collaboration opportunities.

Get in touch.

We’d love to chat about how AIBODY can help you.